Elucidating the weak protein-protein interaction mechanisms behind the liquid-liquid phase separation of a mAb solution by different types of additives-Reference-Cited by-同舟云学术

Elucidating the weak protein-protein interaction mechanisms behind the liquid-liquid phase separation of a mAb solution by different types of additives

Published:2017-11 Issue: Volume:120 Page:1-8
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Wu Guoliang,Wang Shujing,Tian Zhou,Zhang Ning,Sheng Han,Dai Weiguo,Qian Feng

Funder

Janssen Pharmaceuticals, Inc.

Johnson & Johnson

Center for Life Sciences at Tsinghua and Peking Universities (Beijing, China)

Office of China Postdoctoral Council

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference31 articles.

1. Monoclonal antibodies – a proven and rapidly expanding therapeutic modality for human diseases;An;Protein Cell,2010

2. Development trends for human monoclonal antibody therapeutics;Nelson;Nat. Rev. Drug Disc.,2010

3. Building better monoclonal antibody-based therapeutics;Weiner;Nat. Rev. Cancer,2015

4. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies;Mitragotri;Nat. Rev. Drug Disc.,2014

5. High concentration formulation feasibility of human immunoglubulin G for subcutaneous administration;Dani;J. Pharmaceut. Sci.,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A workflow for the development of template-assisted membrane crystallization downstream processing for monoclonal antibody purification;Nature Protocols;2023-09-11

2. The Relationship between Protein–Protein Interactions and Liquid–Liquid Phase Separation for Monoclonal Antibodies;Molecular Pharmaceutics;2023-04-11

3. Conformational Changes and Drivers of Monoclonal Antibody Liquid-Liquid Phase Separation;Journal of Pharmaceutical Sciences;2023-03

4. Advanced Formulations/Drug Delivery Systems for Subcutaneous Delivery of Protein-Based Biotherapeutics;Journal of Pharmaceutical Sciences;2022-11

5. Opalescence Measurements: Improvements in Fundamental Knowledge, Identifying Sources of Analytical Biases, and Advanced Applications for the Development of Therapeutic Proteins;Journal of Pharmaceutical Sciences;2021-11